Zymeworks (ZYME) Change in Taxes (2022 - 2026)
Zymeworks' (ZYME) quarterly Change in Taxes came in at -$16000.0 in Q1 2026, down 1500.0% year-on-year from $1142.9 in Q1 2025, and up 98.29% quarter-over-quarter from -$933000.0 in Q4 2025.
Zymeworks (ZYME) Change in Taxes (2022 - 2026) Analysis & Trends
Zymeworks has disclosed Change in Taxes across 5 years of filings, most recently posting -$16000.0 for Q1 2026.
- Change in Taxes for Q1 2026 came in at -$16000.0, down 1500.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$60000.0 (up 96.54% YoY), and the FY2025 annual result was -$45000.0, up 97.32% from the prior year.
- Change in Taxes came in at -$16000.0 for Q1 2026 at Zymeworks, up from -$933000.0 in the prior quarter.
- In the past five years, Change in Taxes ranged from a high of $979000.0 in Q4 2023 to a low of -$1.9 million in Q4 2024.
- The 5-year median for Change in Taxes is $50000.0 (2024), against an average of $5153.8.
- Across the five-year window, Change in Taxes jumped 567.88% in 2025 and plunged 1500.0% in 2026, its largest moves.
- Zymeworks' Change in Taxes stood at $840000.0 in 2022, then rose by 16.55% to $979000.0 in 2023, then tumbled by 298.47% to -$1.9 million in 2024, then surged by 51.98% to -$933000.0 in 2025, then jumped by 98.29% to -$16000.0 in 2026.
- The last three Change in Taxes figures came in at -$16000.0 (Q1 2026), -$933000.0 (Q4 2025), and $915000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Zymeworks | 1.73 Bn | 1.36 Bn | - | -16,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16,000.00 |
| Mar 31, 2026 | -16,000.00 |
| Dec 31, 2025 | -933,000.00 |
| Dec 31, 2025 | -933,000.00 |
| Sep 30, 2025 | 915,000.00 |
| Sep 30, 2025 | 915,000.00 |
| Jun 30, 2025 | -26,000.00 |
| Jun 30, 2025 | -26,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Dec 31, 2024 | -1.94 Mn |
| Dec 31, 2024 | -1.94 Mn |
| Sep 30, 2024 | 137,000.00 |
| Sep 30, 2024 | 137,000.00 |
| Jun 30, 2024 | 74,000.00 |
| Jun 30, 2024 | 74,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 979,000.00 |
| Dec 31, 2023 | 979,000.00 |